Moderna (NASDAQ: MRNA) reported Q1 EPS of $0.19, $1.94 better than the analyst estimate of ($1.75). Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.18 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.